Stephanie Willerth

CEO

Dr. Willerth is a full professor of Biomedical Engineering who runs an active research group that investigates how to engineer neural tissue from pluripotent stem cells. Her research group has developed many types of biomaterial scaffolds for promoting the differentiation of induced pluripotent stem cells (iPSCs) into neural phenotypes for tissue engineering applications, such as screening the toxicity of drugs, learning about how tissues form during development and replacing dysfunctional tissues. She founded Axolotl Biosciences with the goal of bioprinting neural tissues easily accessible to scientists and engineering from a range of backgrounds.